Economic_NewsAstraZeneca wins shareholder approval for New York listing Rutt ontrd12 months ago01 mins Post Views: 239 Move by FTSE’s biggest company gains support of 99% of shareholders who voted in blow to London market 0 Reviews Post navigation Previous: AstraZeneca wins vote to press ahead with New York listingNext: Gold Price Forecast: XAU/USD failing to retain $4,000 amid broad US Dollar demand
Carney’s energy ambitions boosted by Conservative victory in British Columbia Rutt ontrd5 hours ago 0
Mercuria challenging the ‘Dow Jones of shipping’ in court after Hormuz losses Rutt ontrd15 hours ago 0